Prevalence and Risk Factors for Pain and Related Adverse Reactions Among Breast Cancer Survivors on Aromatase Inhibitors

NCT05628077 · clinicaltrials.gov ↗

UNKNOWN

Status

1200

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Aromatase Inhibitors
Endocrine Therapy
Pain
Anxiety
Depression
Sleep

Interventions

OTHER: No intervention

Sponsor

Peking University People's Hospital